News About: Pharm. Industry
Yuhan Corporation generates 21 blockbuster drugs recording over KRW 10 billion sales
It was observed Yuhan Corporation made KRW 140 billion sales with the hepatitis B treatment ‘Viread’ last year.
Moreover, the company was recorded to spend 6.5% of sales, KRW 85.2 billion, into R&D.
With Viread whic...
Hanmi Pharm registers International Nonproprietary Name for its new immune disorder treatment
Hanmi Pharm(CEO Gwan-Sun Lee) decided a name of the self-developed new drug ‘HM71224’ for the treatment of immune system disorder on ‘Poseltinib.’
Hanmi Pharm announced on the 7th ‘Poseltinib’ was recently registered...
No place for drug rebates, it is not ‘option’ but ‘must-follow’ for pharmas
Rebates incidents, which have depressed pharmaceutical companies every time they occur, have become an old word. Although some pharmaceutical companies are still being investigated for rebate and there is a word that ...
Huons accelerates Phase 2 clinical trials for new dry eye biologic in U.S.
Huons Co. Ltd., a holding company of Huons Global Co. Ltd., announced on the 6th that it signed agreements with sample manufacturing companies and contract service organizations for clinical trials to accelerate the c...
Biowood will target infertility market with Korea’s first and only private sperm bankOn the last 28th of February, Biowood(CEO Sung-Hoon Ahn), a subsidiary of Kemimedi(CEO Gun-Seop Choi), a company specializing in developing new drugs for treatment of rare and i...
|
Pharmaking provided KRW 14 billion rebates to 2,000 hospitals and clinics in KoreaThe Fair Trade Commission(Chairman Jae-Chan Jeong, hereinafter referring to FTC) decided to impose a correction order and a KRW 2.169 billion fine on Pharmaking which provided d...
|
Pharmas’ growth will continue this year, challenging over 10% or even 20% growth in sales
Pharmaceutical companies have set a goal to continue with their double-digit growth rate in this year’s circumstance where it is hard to predict anything. Some pharmaceutical companies, in particular, will encounter a...
Dong Wha Pharm signs exclusive sales agreement of FDA-approved adhesive barrier with Genzyme Korea
Dong Wha Pharm(Chairman Doh-Joon Yoon) signed an exclusive distribution and sales agreement of the deep-cavity wound dressing Seprafilm(adhesion barrier) to Korea with the Sanofi Group’s corporate body of specialty ca...
Pharmas turning eyes to OTC drugs, what is this year’s ‘keyword’ for marketing?
As a part of the growth and profitable business management, pharmaceutical companies have focused on the over-the-counter(OTC) drug market this year.
They have made use of various strategies to promote their OTC prod...
Korea Pharmaceutical Ind. Coop. will be led by Chairman Yong-Joon Cho next 4 years
Korea Pharmaceutical Ind. Coop. held the 53rd regular general meeting on the 28th and decided reappointment of the current chairman Yong-Joon Cho(Dong-Koo Bio&Pharma CEO).
Chairman Yong-Joon Cho was appointed as the ...
